Impaired pulmonary defense against Pseudomonas aeruginosa in VEGF gene inactivated mouse lung
Breen E. C. / Malloy J. L. / Tang K. / Xia F. / Fu Z. / Hancock R. E.W. / Overhage J. / Wagner P. D. / Spragg R. G. (2012)
Journal of Cellular Physiology 228 (2012) 371–379
- Datum: 2012
Breen E. C. / Malloy J. L. / Tang K. / Xia F. / Fu Z. / Hancock R. E.W. / Overhage J. / Wagner P. D. / Spragg R. G. (2012): „Impaired pulmonary defense against Pseudomonas aeruginosa in VEGF gene inactivated mouse lung“. In: Journal of Cellular Physiology 228 (2012) 371–379
Repeated bacterial and viral infections are known to contribute to worsening lung function in several respiratory diseases, including asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). Previous studies have reported alveolar wall cell apoptosis and parenchymal damage in adult pulmonary VEGF gene ablated mice. We hypothesized that VEGF expressed by type II cells is also necessary to provide an effective host defense against bacteria in part by maintaining surfactant homeostasis.
Therefore, Pseudomonas aeruginosa (PAO1) levels were evaluated in mice following lung-targeted VEGF gene inactivation, and alterations in VEGF-dependent type II cell function were evaluated by measuring surfactant homeostasis in mouse lungs and isolated type II cells. In VEGF-deficient lungs increased PAO1 levels and pro-inflammatory cytokines, TNFα and IL-6, were detected 24 h after bacterial instillation compared to control lungs. In vivo lung-targeted VEGF gene deletion (57% decrease in total pulmonary VEGF) did not alter alveolar surfactant or tissue disaturated phosphatidylcholine (DSPC) levels.
However, sphingomyelin content, choline phosphate cytidylyltransferase (CCT) mRNA, and SP-D expression were decreased. In isolated type II cells an 80% reduction of VEGF protein resulted in decreases in total phospholipids (PL), DSPC, DSPC synthesis, surfactant associated proteins (SP)-B and -D, and the lipid transporters, ABCA1 and Rab3D. TPA-induced DSPC secretion and apoptosis were elevated in VEGF-deficient type II cells. These results suggest a potential protective role for type II cell-expressed VEGF against bacterial initiated infection.